Polynucleotides encoding human oncostatin M antibodies
US9587018B2 · kind B2 · utility
0Cited by
23References
21Claims
0Family size
Inventors
Key dates
| Filing date | Sep 30, 2015 |
| Grant date | Mar 7, 2017 |
| Priority date | — |
| Expiry date | Sep 30, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antibodies and compositions capable of neutralizing oncostatin M biological functions are useful in treating diseases and disorders associated with oncostatin M, such as osteoarthritis and idiopathic pulmonary fibrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.